文献速递消化道肿瘤放疗放疗物理与技术

直肠癌术后复发解剖分布与放疗靶区优化:大规模真实世界研究

Anatomic distribution of postoperative recurrence and radiotherapy target volume optimization in rectal cancer: A large-scale real-world study.
PubMed 文献 · Radiother Oncol · 2026-05-23

该研究回顾性分析2006—2024年2530例接受全直肠系膜切除术的直肠癌患者,用概率图谱刻画术后复发解剖模式并测量复发与尾骨尖平面距离。盆底复发率0.75%,中高位直肠癌野内复发最尾端仍高于尾骨尖,提示常规照射远端直肠系膜获益有限,支持选择性降级远端CTV,但需前瞻性验证。

要点

  • 盆底复发率0.75%,高位直肠亚组未见盆底复发。
  • 中/高位直肠癌最尾端野内复发仍高于尾骨尖平面。
  • 常规覆盖远端直肠系膜获益有限,支持选择性降级远端CTV。

核心结论

  • 本队列直肠癌术后盆底复发罕见,事件数少未能确定生存分析,未检测到与总生存的统计学显著关联(HR 0.986;95% CI 0.139-7.018)。
  • 中/高位直肠癌野内复发尾侧边界位于尾骨尖头侧,提示常规远端直肠系膜覆盖获益有限。
  • 这些解剖复发数据为选择性降级远端CTV提供探索性支持,临床实施前需基于治疗计划剂量学评估的前瞻性验证。

研究设计与样本

  • 回顾性分析2006—2024年单中心2530例接受全直肠系膜切除术(TME)的直肠癌患者,采用规范化术后随访。
  • 生存用Kaplan-Meier法评估,独立预测因素用Cox比例风险模型识别。
  • 复发地形用基于配准的体素级概率图谱可视化,并量化每个复发灶下缘至尾骨尖平面的垂直距离。
  • 在保留括约肌患者中用低位前切除综合征(LARS)评分评估肠功能。

主要发现

  • 总体队列盆底复发率为0.75%,高位直肠亚组未观察到盆底复发。
  • 复发独立预测因素包括非结直肠恶性肿瘤家族史、低分化、手术方式、pT4分期、pN阳性及M1疾病。
  • 与开腹手术相比,腹腔镜手术与更低的复发风险相关。
  • 排除盆底、吻合口及内脏复发后,中/高位直肠癌最尾端野内复发仍高于尾骨尖(中直肠:56.88 mm [45.21-68.56];高直肠:64.18 mm [45.35-83.01])。
  • 长期肠功能良好:125例(88.65%)LARS评分≤20,6例(4.26%)为21-29分,10例(7.09%)≥30分。

关键数值与推荐

  • 盆底复发率0.75%,高位直肠亚组无盆底复发。
  • 中直肠最尾端野内复发距尾骨尖56.88 mm(95%CI 45.21-68.56)。
  • 高直肠最尾端野内复发距尾骨尖64.18 mm(95%CI 45.35-83.01)。
  • LARS评分≤20者125例(88.65%),21-29分者6例(4.26%),≥30分者10例(7.09%)。

临床怎么用

  • 中/高位直肠癌术前放疗可考虑选择性降级远端CTV,减少远端直肠系膜常规照射。
  • 降级决策应结合复发独立预测因素(如pT4、pN阳性、低分化等)个体化评估。
  • 实施前需基于治疗计划剂量学评估的前瞻性验证。

局限性

  • 盆底复发事件数少,生存分析受限,未检测到与总生存的统计学显著关联。
  • 解剖复发数据为探索性支持,需前瞻性验证后方可临床实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize the anatomic pattern of postoperative recurrence in rectal cancer and determine whether irradiation of the distal mesorectum is necessary during preoperative radiotherapy, thereby informing safe target-volume reduction. METHODS: We retrospectively analyzed 2,530 patients with rectal cancer who underwent total mesorectal excision (TME) at our institution between 2006 and 2024, with protocolized postoperative follow-up. Survival was evaluated using Kaplan-Meier methods, and independent predictors were identified with Cox proportional hazards models. Recurrence topography was visualized using a registration-based, voxel-wise probabilistic atlas. We quantified the vertical distance from the caudal edge of each recurrence to the coccygeal tip plane. In sphincter-preserved patients, bowel function was assessed with the Low Anterior Resection Syndrome (LARS) score. RESULTS: In the overall cohort, pelvic-floor recurrence occurred in 0.75%; no pelvic-floor recurrence was observed in the high rectal subgroup. Pelvic-floor recurrence was rare, and no statistically significant difference in survival outcomes was observed; however, this comparison was limited by the small number of events. Independent predictors of recurrence included family history of non-colorectal malignancy, poor differentiation, surgical approach, pT4 stage, pN positivity, and M1 disease. Compared with open surgery, laparoscopic surgery was associated with a lower risk of recurrence. After excluding pelvic-floor, anastomotic, and visceral recurrences, the most caudal in-field recurrence in mid/high rectal cancer remained above the coccygeal tip (mid rectum: 56.88 mm [45.21-68.56]; high rectum: 64.18 mm [45.35-83.01]). Long-term bowel function was favorable: 125 patients (88.65%) had LARS scores ≤ 20, 6 (4.26%) had scores of 21-29, and 10 (7.09%) had scores ≥ 30. CONCLUSIONS: Pelvic-floor recurrence after rectal cancer surgery was rare in this cohort. The small number of events precluded a definitive survival analysis, and no statistically significant association with overall survival was detected (HR 0.986; 95% CI 0.139-7.018). In mid/high rectal cancer, the caudal boundary of in-field recurrence lies cranial to the coccygeal tip, suggesting limited benefit from routine distal mesorectal coverage. These anatomic recurrence data provide exploratory support for selective distal CTV de-escalation in mid/high rectal cancer, but prospective validation with treatment-plan-based dosimetric assessment is required before clinical implementation.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Lin Q, Cai H, et al. Anatomic distribution of postoperative recurrence and radiotherapy target volume optimization in rectal cancer: A large-scale real-world study. Radiother Oncol. 2026. PMID: 42177995. doi:10.1016/j.radonc.2026.111604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。